null (Genvor Incorporated) Aktie
GNVR
GeschlossenGenvor Incorporated
Market Cap
$6,401,197
Über null (Genvor Incorporated) Aktie
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.
Unternehmensinformationen
89012 Henderson, United States
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.